FDA Drug Recalls

Recalls / Class I

Class ID-336-2013

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

Mojo nights Capsules, Male Sexual Enhancer, supplied in 1 and 5 count blister packs, Distributed By: Mojo Health, Pompano Beach, FL I count blister UPC - 718122119738; 5 count blister UPC - 705105836430;

Affected lot / code info
(1 count) Lot# 01MJ0712, (1 count) 01MM0211 Exp: 07/15; (5 count) Lot# 05M0912, Exp: 10/15;

Why it was recalled

Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs

Recalling firm

Firm
Performance Plus Marketing, Inc.
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
5560 E 61st St, Commerce, California 90040-3406

Distribution

Quantity
219,000 capsules.
Distribution pattern
Nationwide

Timeline

Recall initiated
2012-12-17
FDA classified
2013-05-16
Posted by FDA
2013-05-22
Terminated
2013-11-14
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-336-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class I recall: drug · FDA Drug Recalls